Randomised controlled trial of one week strict low-iodine diet versus one week non-specified low iodine diet in differentiated thyroid carcinoma

Document Type: Original Article

Authors

1 Department of Nuclear Medicine, Radiotherapy and Oncology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

2 Hospital Universiti Sains Malaysia (HUSM), Kubang Kerian, Kelantan, Malaysia

3 Advanced Medical and Dental Institution, Universiti Sains Malaysia, Kepala Batas, Penang, Malaysia

4 Unit of Biostatistics and Research Methodology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

5 Nutrition and Dietetic Programme, School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

Abstract

Introduction: A low iodine diet (LID) is recommended prior to the Radioactive Iodine-131 (RAI) treatment or scanning in differentiated thyroid carcinoma (DTC) post total thyroidectomy. However, recommended strictness of LID is varying among major guidelines. This study was aim to investigate the patient’s compliance to LID by measuring the urinary iodine level post LID.
Methods: A total of one hundred and four patients of DTC post total thyroidectomy patients that were planned for treatment or scanning were enrolled into the study. 55 patients are subjected to 1-week strict LID while the other 49 patients are subjected to 1-week non-specified LID before RAI administration. Baseline urinary iodine level were obtained prior to the LID and second urinary iodine level were measured at day-8 or prior to RAI administration.
Results:The compliance rate of patients that achieved urinary iodine level less than 100ug/L following 1-week strict LID was 89.1% as for the 1-weeks non-specified LID was 91.8% which did not show any significant difference between the two LID group (p=0.746). After 7 days institution of non-specified LID, the mean urinary iodine level was significantly reduced about 40.8% compared to strict LID (36.3%).
Conclusion: The 1 week of non-specified LID is effective enough to decrease the urinary iodine level in low iodine intake area and the longer duration of LID is more hindrance for the patient to comply.

Keywords

Main Subjects


  1. Sawka AM, Ibrahim-Zada I, Galacgac P, Tsang RW, Brierley JD, Ezzat S, Goldstein DP. Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review. Thyroid. 2010 Oct;20(10):1129-38.
  2. Pluijmen MJ, Eustatia-Rutten C, Goslings BM, Stokkel MP, Arias AM, Diamant M, Romijn JA, Smit JW. Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf). 2003 Apr;58(4):428-35.
  3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.
  4. Uyttersprot N, Pelgrims N, Carrasco N, Gervy C, Maenhaut C, Dumont JE, Miot F. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid. Mol Cell Endocrinol. 1997 Aug 8;131(2):195-203.
  5. Perros P, Colley S, Boelaert K, Evans C, Evans RM, Gerrard GE, Gilbert JA, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold KL, Taylor J, Thakker RV, Watkinson J, Williams GR. Guidelines for the management of thyroid cancer. Clin Endocrinol. 2014;81(Suppl 1):1-122.
  6. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E; European Association of Nuclear Medicine (EANM). Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59.
  7. Kim HK, Lee SY, Lee JI, Jang HW, Kim SK, Chung HS, Tan AH, Hur KY, Kim JH, Chung JH, Kim SW. Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area. Clin Endocrinol (Oxf). 2011 Dec;75(6):851-6.
  8. Zainal OA, Nor Saleha IT, Zainuddin MA. National cancer registry report 2006: Malaysia cancer statistics - data and figure. Ministry of Health, Malaysia; 2006.
  9. Elisei R, Lorenzoni A, Borso E, Boni G, Klain M, Salvatore M, Soricelli A, Ferdeghini M, Mariani G. Thyroid and Parathyroid Tumors. In: Strauss HW, Mariani G, Volterrani D, Larson SM. (Eds.) Nuclear oncology: From pathophysiology to clinical applications. New York: Springer; 2013. p. 297-62.
  10. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer. 1997 Feb 1;79(3):564-73.
  11. Selamat R, Mohamud WN, Zainuddin AA, Rahim NS, Ghaffar SA, Aris T. Iodine deficiency status and iodised salt consumption in Malaysia: findings from a national iodine deficiency disorders survey. Asia Pac J Clin Nutr. 2010;19(4):578-85.
  12. Park JT 2nd, Hennessey JV. Two-week low iodine diet is necessary for adequate outpatient preparation for radioiodine rhTSH scanning in patients taking levothyroxine. Thyroid. 2004 Jan;14(1):57-63.
  13. Haap M, Roth HJ, Huber T, Dittmann H, Wahl R. Urinary iodine: comparison of a simple method for its determination in microplates with measurement by inductively-coupled plasma mass spectrometry. Sci Rep. 2017 Jan 3;7:39835.
  14. Hussain H, Khalid NM, Selamat R, Wan Nazaimoon WM. Evaluation of the performance of a micromethod for measuring urinary iodine by using six sigma quality metrics. Ann Lab Med. 2013 Sep;33(5):319-25.
  15. Ohashi T, Yamaki M, Pandav CS, Karmarkar MG, Irie M. Simple microplate method for determination of urinary iodine. Clin Chem. 2000 Apr;46(4):529-36.